Aug. 3, 2021, 10:15 a.m.
(Forbes) Publicly traded healthcare companies operating in China have a major bribery problem. It now seems that problem extends to their distributors and resellers.
Login to grade this article.
Aug. 3, 2021, 10:15 a.m.
(Forbes) Publicly traded healthcare companies operating in China have a major bribery problem. It now seems that problem extends to their distributors and resellers.
Login to grade this article.